BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3259826)

  • 1. Differentiation between small benign and malignant adrenal masses with dynamic incremented CT.
    Berland LL; Koslin DB; Kenney PJ; Stanley RJ; Lee JY
    AJR Am J Roentgenol; 1988 Jul; 151(1):95-101. PubMed ID: 3259826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphologic features of 211 adrenal masses at initial contrast-enhanced CT: can we differentiate benign from malignant lesions using imaging features alone?
    Song JH; Grand DJ; Beland MD; Chang KJ; Machan JT; Mayo-Smith WW
    AJR Am J Roentgenol; 2013 Dec; 201(6):1248-53. PubMed ID: 24261363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values.
    Korobkin M; Brodeur FJ; Yutzy GG; Francis IR; Quint LE; Dunnick NR; Kazerooni EA
    AJR Am J Roentgenol; 1996 Mar; 166(3):531-6. PubMed ID: 8623622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced sonography of adrenal masses: differentiation of adenomas and nonadenomatous lesions.
    Friedrich-Rust M; Schneider G; Bohle RM; Herrmann E; Sarrazin C; Zeuzem S; Bojunga J
    AJR Am J Roentgenol; 2008 Dec; 191(6):1852-60. PubMed ID: 19020259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT.
    Peña CS; Boland GW; Hahn PF; Lee MJ; Mueller PR
    Radiology; 2000 Dec; 217(3):798-802. PubMed ID: 11110946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of adrenal adenoma and nonadenoma in unenhanced CT: new optimal threshold value and the usefulness of size criteria for differentiation.
    Park SH; Kim MJ; Kim JH; Lim JS; Kim KW
    Korean J Radiol; 2007; 8(4):328-35. PubMed ID: 17673844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay.
    Blake MA; Kalra MK; Sweeney AT; Lucey BC; Maher MM; Sahani DV; Halpern EF; Mueller PR; Hahn PF; Boland GW
    Radiology; 2006 Feb; 238(2):578-85. PubMed ID: 16371582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of relative wash-in ratio of adrenal lesions at early biphasic CT.
    Foti G; Faccioli N; Manfredi R; Mantovani W; Mucelli RP
    AJR Am J Roentgenol; 2010 Jun; 194(6):1484-91. PubMed ID: 20489087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of Benign From Metastatic Adrenal Masses in Patients With Renal Cell Carcinoma on Contrast-Enhanced CT.
    Sasaguri K; Takahashi N; Takeuchi M; Carter RE; Leibovich BC; Kawashima A
    AJR Am J Roentgenol; 2016 Nov; 207(5):1031-1038. PubMed ID: 27556736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiologic characterization of adrenal masses: the role of computed tomography--derived attenuation values.
    Nwariaku FE; Champine J; Kim LT; Burkey S; O'keefe G; Snyder WH
    Surgery; 2001 Dec; 130(6):1068-71. PubMed ID: 11742340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidental indeterminate adrenal mass on CT (> 10 H) in patients without cancer: is further imaging necessary? Follow-up of 321 consecutive indeterminate adrenal masses.
    Song JH; Chaudhry FS; Mayo-Smith WW
    AJR Am J Roentgenol; 2007 Nov; 189(5):1119-23. PubMed ID: 17954649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis.
    Lee MJ; Hahn PF; Papanicolaou N; Egglin TK; Saini S; Mueller PR; Simeone JF
    Radiology; 1991 May; 179(2):415-8. PubMed ID: 2014283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed enhanced CT for differentiation of benign from malignant adrenal masses.
    Korobkin M; Brodeur FJ; Francis IR; Quint LE; Dunnick NR; Goodsitt M
    Radiology; 1996 Sep; 200(3):737-42. PubMed ID: 8756924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenal masses: characterization with delayed contrast-enhanced CT.
    Boland GW; Hahn PF; Peña C; Mueller PR
    Radiology; 1997 Mar; 202(3):693-6. PubMed ID: 9051018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computed tomography in primary and secondary adrenal tumours.
    Päivänsalo M; Lähde S; Merikanto J; Kallionen M
    Acta Radiol; 1988; 29(5):519-22. PubMed ID: 3166873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystic adrenal lesions: CT features.
    Rozenblit A; Morehouse HT; Amis ES
    Radiology; 1996 Nov; 201(2):541-8. PubMed ID: 8888255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal masses in patients with cancer: PET/CT characterization with combined CT histogram and standardized uptake value PET analysis.
    Perri M; Erba P; Volterrani D; Guidoccio F; Lazzeri E; Caramella D; Mariani G
    AJR Am J Roentgenol; 2011 Jul; 197(1):209-16. PubMed ID: 21701032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of PET/CT in differentiating benign from malignant adrenal nodules in patients with cancer.
    Vikram R; Yeung HD; Macapinlac HA; Iyer RB
    AJR Am J Roentgenol; 2008 Nov; 191(5):1545-51. PubMed ID: 18941099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT.
    Caoili EM; Korobkin M; Francis IR; Cohan RH; Platt JF; Dunnick NR; Raghupathi KI
    Radiology; 2002 Mar; 222(3):629-33. PubMed ID: 11867777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of malignant from benign adrenal masses: predictive indices on computed tomography.
    Hussain S; Belldegrun A; Seltzer SE; Richie JP; Gittes RF; Abrams HL
    AJR Am J Roentgenol; 1985 Jan; 144(1):61-5. PubMed ID: 3871149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.